Division of Nephrology and Hypertension, Department of Internal Medicine, and William von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA.
Am J Transplant. 2012 May;12(5):1199-207. doi: 10.1111/j.1600-6143.2011.03911.x. Epub 2012 Jan 5.
This study assessed the development of allograft interstitial fibrosis and inflammation (GIF+"i"), a histologic pattern associated with reduced graft survival. Included are 795 adults, recipients of kidney allografts from 2000 to 2006. GIF+"i" was diagnosed in surveillance and clinical biopsies that had no transplant glomerulopathy. With time, posttransplant increasing number of grafts showed GIF+"i" and these patients had reduced death-censored graft survival (HR = 4.33 (2.49-7.53), p < 0.0001). Development of GIF+"i" was related to prior acute cellular rejection (ACR), BK nephropathy (PVAN), increasing number of HLA mismatches, retransplantation and DGF. However, 46.4% of GIF+"i" cases had no history of ACR or PVAN. Anti-HLA antibodies at transplant did not relate to GIF+"i" and these patients had no increased frequency of new antibody formation posttransplant. Post-ACR biopsies showed that GIF+"i" developed more commonly after clinically and/or histologically more severe ACR. Graft inflammation persisted in 38.7 and 29.6% of grafts 2 and 12 months post-ACR. Twelve months post-ACR, 27.1% of biopsies developed moderate-severe GIF and 51.8% showed GIF and inflammation. Persistent inflammation and progressive GIF is often subclinical but may lead to graft failure. GIF+"i" can be initiated by multiple etiologies but it is often postinfectious or due to persistent cellular immune-mediated injury.
本研究评估了同种异体移植物间质纤维化和炎症(GIF+"i")的发展,这种组织学模式与移植物存活率降低有关。研究对象包括 795 名成年人,他们在 2000 年至 2006 年期间接受了肾移植。GIF+"i"是在没有移植肾小球病的监测和临床活检中诊断出来的。随着时间的推移,越来越多的移植后发生 GIF+"i"的患者出现了死亡风险的移植物存活率降低(HR=4.33(2.49-7.53),p<0.0001)。GIF+"i"的发展与既往急性细胞排斥反应(ACR)、BK 肾病(PVAN)、HLA 错配数量增加、再次移植和 DGF 有关。然而,46.4%的 GIF+"i"病例没有 ACR 或 PVAN 的病史。移植时的抗 HLA 抗体与 GIF+"i"无关,这些患者在移植后没有增加新抗体形成的频率。在 ACR 后活检中,在临床上和/或组织学上更严重的 ACR 后,更常见的是 GIF+"i"的发展。移植后 2 个月和 12 个月,移植炎症在 38.7%和 29.6%的移植中持续存在。ACR 后 12 个月,27.1%的活检显示中度至重度 GIF,51.8%显示 GIF 和炎症。持续的炎症和进行性的 GIF 通常是亚临床的,但可能导致移植物衰竭。GIF+"i"可以由多种病因引起,但通常是感染后或由于持续的细胞免疫介导的损伤。